Reliable Lighting for Commercial Cannabis Production: Three Disciplines That Ensure Highly Reliable Grow Lights - Get the Free Report

Reliable Lighting for Commercial Cannabis Production: Three Disciplines That Ensure Highly Reliable Grow Lights - Get the Free Report

Expect Cannabis to Be 'Sold-Out' Across Canada, Says Aphria | Cannabis Business Times

Sign in or create a free Cannabis Business Times account to continue reading

Continue to Site »
Site will load in 15 seconds

Continue to Site »X

Expect Cannabis to Be 'Sold-Out' Across Canada, Says Aphria

"There will not be any complete satisfaction by any of the provincial regulators out of the box," Aphria's CEO says.

Canada

October 15, 2018

Licensed cannabis producer Aphria Inc. warned on Friday of product shortages in both brick-and-mortar stores and online sales portals across the country when recreational pot is legalized in a few days.

There are "supply chain issues abounding everywhere with every LP," said Aphria's chief executive Vic Neufeld told analysts.

"There will not be any complete satisfaction by any of the provincial regulators out of the box," he said during a call to discuss the Leamington, Ont.-based company's latest earnings. "The pipeline fill is not going to be there. But that's just the short term."

"Sold-out signs" on online cannabis sales portals across the country are likely, he added.

Top photo courtesy of Adobe Stock

Shrink Is Eating Into Cannabis Retail Margins - Here’s How to Stop It

The Biggest Things About Schedule III You Haven’t Thought Of

Closing the Hemp Loophole Does Not Mean Your Business Has to Close (Opinion)

Cannabis Workforce Solutions: How Licensed Cultivators, Dispensaries Benefit From Industry-Education Alliances (Opinion)

Impending Hemp Regs ‘a Rattling Shock to the Backbone of the Cannabis Seed Industry’

Brothers Grimm Seeds CEO Laura Campanella shares how she has been working with others to raise awareness about and lobby against regulatory changes that will force underground or destroy genetics, businesses and decades of breeding work.

Brown snail with textured shell resting on vibrant green moss in natural habitat

The Biggest Things About Schedule III You Haven’t Thought Of

Brian Vicente of Vicente LLP talks Schedule III with Cannabis Business Times

Close-up of cannabis flower bud with crystalline trichomes against American flag background

Closing the Hemp Loophole Does Not Mean Your Business Has to Close (Opinion)

Potential changes to the 2018 Farm Bill’s definition of hemp, if enacted, mean businesses will have one year to adapt their operations.

Cannabis Workforce Solutions: How Licensed Cultivators, Dispensaries Benefit From Industry-Education Alliances (Opinion)

As the cannabis industry matures, the integration of targeted workforce and business development training will be essential.

Young professional working at computer in modern office with colleagues in background

The Race to Nowhere: How Chasing Potency Undermines Cannabis Quality (Opinion)

The current THC labeling system is misleading, and consumers deserve more accurate, meaningful information.

Man in gray coat standing in front of colorful graffiti wall with opinion text

German Cannabis Market Establishes Foundation for Global Industry Expansion (Op-Ed)

The fact that legal cannabis in Germany is more affordable than the illegal market is revolutionary for the global cannabis industry to date.

Global cannabis industry map highlighting Germany's role in international marijuana market

Innovating for the Benefit of Patients in Medical Cannabis (Opinion)

Poor bioavailability formulations in orally delivered medical cannabis have left an innovation gap for patients.

Stenocare 365250395

Rescheduling Update: How Long Is the Wait? What’s Next?

Government affairs and policy expert David Mangone tells us what we can expect from the DEA as weeks pass following the public comment period, including insights on the DEA’s final review and if a hearing is likely to be granted.

David Mangone Interview Top Story Image

Mitch Meyers on How to 'Manage the Chaos' in Cannabis

The founder of Missouri's BeLeaf Medical says women are 'uniquely suited' to be leaders in the male-dominated industry.

Mitch Meyers, founder, BeLeaf Medical

7 Takeaways From the Feds' Cannabis Rescheduling Recommendation

Attorney Jonathan Havens outlines what stood out for him most after reviewing the 252-page document released by the U.S. Department of Health & Human Services.

Opinion Top Story Havens 948x514

Opinion: The Cannabis Industry Must Prioritize Worker Safety, Invest in PPE

The hazards associated with cannabis production are well-documented, and it's time for the industry to step up and prioritize the health and safety of its employees.

Opinion Top Story Roggen 948x514

Federal Government Continues to Withhold Key Cannabis Scheduling Recommendation Letter Despite FOIA Requests, Lawsuit

After nearly three months and multiple Freedom of Information Act requests, the U.S. Department of Health and Human Services still has not publicly confirmed that it recommended cannabis be reclassified as a Schedule III controlled substance. One attorney who filed a lawsuit to obtain the letter calls the situation "asinine" and "profoundly disappointing."

A screenshot of the redacted letter from the U.S. Department of Health and Human Services Cannabis Business Times received in response to its Freedom of Information Act Request.

Page 1 of 51